Form 4: REGENXBIO Officer's Tax-Related Stock Disposition
Insider Transaction Report
REGENXBIO's Chief Strategy & Legal Officer, Patrick J. Christmas, reported a disposition of 4,700 common shares to cover tax obligations related to vested restricted stock units.
Summary
- Patrick J. Christmas, Chief Strategy & Legal Officer of REGENXBIO Inc., reported a disposition of 4,700 shares of common stock.
- This disposition was to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) that were originally granted on August 1, 2024.
- The shares were valued at $11.16 per share for tax purposes, based on the closing price of the issuer's common stock on February 1, 2026.
- Following this transaction, Mr. Christmas beneficially owns 210,667 shares of REGENXBIO common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction for tax purposes, which does not reflect a change in the reporting person's investment thesis or the company's operational performance.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that tax-related dispositions of shares upon restricted stock unit vesting are a common and routine aspect of executive compensation. Such transactions are generally not indicative of management's sentiment towards the company's future prospects, unlike open market sales.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine tax-related disposition, not a voluntary sale, and does not signal a change in the executive's confidence.
- Employees: Reflects standard equity compensation practices for executives within the company.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Original grant date of restricted stock units to the reporting person. |
| 02/01/2026 | Transaction date for the disposition of shares to pay taxes upon RSU vesting. |
| 02/03/2026 | Date the Form 4 was filed. |
Recommendation
holdThis Form 4 reports a routine tax-related disposition of shares upon RSU vesting by an executive. It does not signal any change in the company's fundamentals or the executive's long-term view, thus it provides no new information to alter an existing investment thesis.
Keywords
REGENXBIO, RGNX, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, Patrick J. Christmas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.